BDBM50102924 5-(3-Bromo-phenyl)-7-(6-pyrrolidin-1-yl-pyridin-3-yl)-pyrido[2,3-d]pyrimidin-4-ylamine::CHEMBL302404

SMILES: Nc1ncnc2nc(cc(-c3cccc(Br)c3)c12)-c1ccc(nc1)N1CCCC1

InChI Key: InChIKey=UFGPDCMTYBWKFF-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50102924   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Adenosine kinase (Homo sapiens (Human))	BDBM50102924 (5-(3-Bromo-phenyl)-7-(6-pyrrolidin-1-yl-pyridin-3-...) Show SMILES Nc1ncnc2nc(cc(-c3cccc(Br)c3)c12)-c1ccc(nc1)N1CCCC1 Show InChI InChI=1S/C22H19BrN6/c23-16-5-3-4-14(10-16)17-11-18(28-22-20(17)21(24)26-13-27-22)15-6-7-19(25-12-15)29-8-1-2-9-29/h3-7,10-13H,1-2,8-9H2,(H2,24,26,27,28)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	3.40	n/a	n/a	n/a	n/a	n/a	n/a
Abbott Laboratories Curated by ChEMBL					Assay Description In vitro concentration required for 50% inhibition against Adenosine Kinase (AK) in the presence of intact cells				Bioorg Med Chem Lett 11: 2071-4 (2001) BindingDB Entry DOI: 10.7270/Q2CN735Q
					More data for this Ligand-Target Pair
Adenosine kinase (Homo sapiens (Human))	BDBM50102924 (5-(3-Bromo-phenyl)-7-(6-pyrrolidin-1-yl-pyridin-3-...) Show SMILES Nc1ncnc2nc(cc(-c3cccc(Br)c3)c12)-c1ccc(nc1)N1CCCC1 Show InChI InChI=1S/C22H19BrN6/c23-16-5-3-4-14(10-16)17-11-18(28-22-20(17)21(24)26-13-27-22)15-6-7-19(25-12-15)29-8-1-2-9-29/h3-7,10-13H,1-2,8-9H2,(H2,24,26,27,28)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	45	n/a	n/a	n/a	n/a	n/a	n/a
Abbott Laboratories Curated by ChEMBL					Assay Description In vitro concentration required for 50% inhibition against Adenosine Kinase (AK) in the presence of intact cells				Bioorg Med Chem Lett 11: 2071-4 (2001) BindingDB Entry DOI: 10.7270/Q2CN735Q
					More data for this Ligand-Target Pair